241 related articles for article (PubMed ID: 36710358)
21. Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Da Silva DM; Enserro DM; Mayadev JS; Skeate JG; Matsuo K; Pham HQ; Lankes HA; Moxley KM; Ghamande SA; Lin YG; Schilder RJ; Birrer MJ; Kast WM
Clin Cancer Res; 2020 Nov; 26(21):5621-5630. PubMed ID: 32816895
[TBL] [Abstract][Full Text] [Related]
22. PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
de la Rochefordiere A; Kamal M; Floquet A; Thomas L; Petrow P; Petit T; Pop M; Fabbro M; Kerr C; Joly F; Sevin E; Maillard S; Curé H; Weber B; Brunaud C; Minsat M; Gonzague L; Berton-Rigaud D; Aumont M; Gladieff L; Peignaux K; Bernard V; Leroy Q; Bieche I; Margogne A; Nadan A; Fourchotte V; Diallo A; Asselain B; Plancher C; Armanet S; Beuzeboc P; Scholl SM
Clin Cancer Res; 2015 Jun; 21(11):2530-7. PubMed ID: 25724520
[TBL] [Abstract][Full Text] [Related]
23. [Current methods of chemoradiotherapy for locally advanced cervical cancer. Options for reduction of side-effects].
Póti Z; Mayer A
Orv Hetil; 2013 May; 154(21):803-9. PubMed ID: 23692874
[TBL] [Abstract][Full Text] [Related]
24. A preliminary study of genes related to concomitant chemoradiotherapy resistance in advanced uterine cervical squamous cell carcinoma.
An JS; Huang MN; Song YM; Li N; Wu LY; Zhan QM
Chin Med J (Engl); 2013 Nov; 126(21):4109-15. PubMed ID: 24229683
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
26. Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity.
Fjeldbo CS; Hompland T; Hillestad T; Aarnes EK; Günther CC; Kristensen GB; Malinen E; Lyng H
EBioMedicine; 2020 Jul; 57():102841. PubMed ID: 32580139
[TBL] [Abstract][Full Text] [Related]
27. Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer.
Zhang Y; Yu M; Jing Y; Cheng J; Zhang C; Cheng L; Lu H; Cai MC; Wu J; Wang W; Lou W; Qiu L; Tan L; Lu H; Yin X; Zhuang G; Di W
Br J Cancer; 2021 Jan; 124(2):414-424. PubMed ID: 33087896
[TBL] [Abstract][Full Text] [Related]
28. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
[TBL] [Abstract][Full Text] [Related]
29. Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.
Cosper PF; McNair C; González I; Wong N; Knudsen KE; Chen JJ; Markovina S; Schwarz JK; Grigsby PW; Wang X
Int J Cancer; 2020 Apr; 146(7):2047-2058. PubMed ID: 31732968
[TBL] [Abstract][Full Text] [Related]
30. SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway.
Yuan LJ; Li JD; Zhang L; Wang JH; Wan T; Zhou Y; Tu H; Yun JP; Luo RZ; Jia WH; Zheng M
Cell Death Dis; 2014 May; 5(5):e1247. PubMed ID: 24853425
[TBL] [Abstract][Full Text] [Related]
31. Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer.
Koch M; Wiese M
J Cancer Res Clin Oncol; 2013 Feb; 139(2):259-67. PubMed ID: 23052694
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
[TBL] [Abstract][Full Text] [Related]
33. GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells.
Yang Z; Sun Q; Guo J; Wang S; Song G; Liu W; Liu M; Tang H
Autophagy; 2019 Apr; 15(4):668-685. PubMed ID: 30394198
[TBL] [Abstract][Full Text] [Related]
34. Effect of concurrent radiochemotherapy and chemotherapy on serum proteins for prospective predictors of patients with HPV induced cervical cancer.
Dasari S; Shouri RN; Rajendra W; Valluru L
Biomed Pharmacother; 2014 Apr; 68(3):315-20. PubMed ID: 24486110
[TBL] [Abstract][Full Text] [Related]
35. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
[TBL] [Abstract][Full Text] [Related]
36. Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancer.
Tian J; Geng Y; Lv D; Li P; Cordova M; Liao Y; Tian X; Zhang X; Zhang Q; Zou K; Zhang Y; Zhang X; Li Y; Zhang J; Ma Z; Shao Y; Song L; Owen GI; Li T; Liu R; Liu Q; Zou L; Zhang Z; Li Z
Int J Cancer; 2019 Nov; 145(9):2547-2557. PubMed ID: 30919951
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy.
Demirci S; Ozsaran Z; Ozsaran A; Yavas F; Demircioglu B; Hanhan M; Dikmen Y; Aras AB
Eur J Gynaecol Oncol; 2012; 33(1):62-7. PubMed ID: 22439408
[TBL] [Abstract][Full Text] [Related]
38. Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer.
Santin AD; Hermonat PL; Hiserodt JC; Chiriva-Internati M; Woodliff J; Theus JW; Barclay D; Pecorelli S; Parham GP
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):737-42. PubMed ID: 9336157
[TBL] [Abstract][Full Text] [Related]
39. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Hiserodt JC; Pecorelli S; Parham GP
Gynecol Oncol; 1998 Aug; 70(2):195-201. PubMed ID: 9740690
[TBL] [Abstract][Full Text] [Related]
40. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer.
Duan R; Li X; Zeng D; Chen X; Shen B; Zhu D; Zhu L; Yu Y; Wang D
Front Immunol; 2020; 11():609337. PubMed ID: 33569057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
